Roluperidone

DB13080InvestigationalSmall molecule

Roluperidone has been used in trials studying the treatment of Schizophrenia.

Chemical structure of Roluperidone
Formula / weight
C22H23FN2O2 · 366.436 g/mol (avg)
Code names
CYR-101

Resolves to

Compound
UNII4P31I0M3BFCAS359625-79-9PubChem9799284
Structure
InChIKeyRNRYULFRLCBRQS-UHFFFAOYSA-NSMILESFC1=CC=C(C=C1)C(=O)CN1CCC(CN2CC3=CC=CC=C3C2=O)CC1
Targets
Q5BJF2TMEM97P28223HTR2A

What you can answer from here — as of September 21, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Roluperidone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In